home / stock / pacb / pacb news


PACB News and Press, Pacific Biosciences of California Inc. From 07/23/25

Stock Information

Company Name: Pacific Biosciences of California Inc.
Stock Symbol: PACB
Market: NASDAQ
Website: pacb.com

Menu

Get PACB Alerts

News, Short Squeeze, Breakout and More Instantly...

PACB - Pacific Biosciences: The Shift To Razor-Blade Economics Could Be A Game Changer

2025-07-23 11:05:00 ET I have written about Pacific Biosciences ("PacBio") ( PACB ) multiple times before. In my last analysis, I stated that the convertible debt the company issued would likely drag the stock. However, now that the company has broken through the $1 level th...

PACB - PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read Sequencing Project, which will involve contributing long-read transcriptome data to one ...

PACB - PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, 2025, at 5:00 pm Eastern Time. The call will be webcast and may be accessed a...

PACB - Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date PR Newswire Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worl...

PACB - Pacific Biosciences of California: Sell Before Potential Reverse Split

2025-06-02 06:01:11 ET Summary Pacific Biosciences of California's stock has plummeted from over $50 to near $1, reflecting severe operational and financial struggles. Revenue growth in 2025 could be pressured by US government budget cuts, and management has already lowered its ye...

PACB - PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The dis...

PACB - Pacific Biosciences: A Mountain Of Red Flags

2025-05-20 17:24:31 ET Summary Pacific Biosciences offers advanced long-read sequencing, simplifying genome assembly and providing higher taxonomic resolution in specific research niches. While earnings were a beat, shrinking sales, high debt, and a poor macro environment do not i...

PACB - Soros Fund adds Redfin, Las Vegas Sands, exits Alibaba, AstraZeneca, others in Q1

2025-05-15 17:04:00 ET More on 13Fs Saudi wealth fund PIF boosts holdings in BE, AMZN; exits BLDP, among Q1 trades Seth Klarman's Baupost adds FIS, SGI stakes, dumps SNRE, HUM, among Q1 moves Jana Partners adds Freshpet, exits Wolfspeed, among other Q1 move...

PACB - PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations from an attorney representing a...

PACB - Pacbio adjusts 2025 revenue guidance to $150M-$170M amid macroeconomic challenges

2025-05-08 19:09:28 ET More on Pacific Biosciences of California Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript Pacific Biosciences of California, Inc. 2025 Q1 - Results - Earnings Call Presentation Pacific Biosciences: Uncertain Fede...

Previous 10 Next 10